02252.HK
Shanghai MicroPort MedBot (Group) Co., Ltd.
HKSE · Healthcare · Medical - Devices · CN
HKD 21.18
+0.00%Year over year
Reported trailing growth
- Revenue
- +540.5%
- EBITDA
- +73.9%
- EBIT
- +64.1%
- EPS
- +60.2%
- Free cash flow
- +78.3%
- Operating cash flow
- +77.6%
Forward estimates
Based on analyst estimates
- Revenue
- +189.0%
- EBITDA
- +185.9%
- EPS
- +112.8%
Three-year CAGR
- Revenue
- +194.4%
- EBITDA
- +76.6%
- EBIT
- +51.9%
- Net income
- +61.1%
- EPS
- +63.6%
- Free cash flow
- +88.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025